Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Biotron to test its antiviral compounds for activity against Zika virus

Feb. 18, 2016

RB launches a Zika Relief Package in response to the global outbreak

Feb. 18, 2016

Zepatier available in U.S.

Feb. 17, 2016

Biota Pharmaceuticals' BTA-585 granted FDA fast track designation

Feb. 17, 2016

Nanjing Sanhome reports compounds for the treatment of HCV infections

Feb. 17, 2016

Novartis patents antibacterial quinolone derivatives

Feb. 17, 2016

Intramuscular administration of obiltoxaximab well tolerated in healthy adults

Feb. 16, 2016

Gilead Sciences discloses antiviral agents

Feb. 16, 2016

MGB Biopharma and UoS sign an agreement to develop novel anti-infective agents

Feb. 16, 2016

Ennaid Therapeutics to develop therapy for Zika virus

Feb. 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...